Boston Scientific Corp Stock Analysis
| BSX Stock | USD 76.27 1.37 1.76% |
IPO Date 18th of May 1992 | 200 Day MA 100.2211 | 50 Day MA 93.9016 | Beta 0.657 |
Boston Scientific Corp holds a debt-to-equity ratio of 0.506. At this time, Boston Scientific's Short and Long Term Debt Total is fairly stable compared to the past year. Net Debt is likely to rise to about 13 B in 2026, whereas Long Term Debt is likely to drop slightly above 5.7 B in 2026. With a high degree of financial leverage come high-interest payments, which usually reduce Boston Scientific's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Boston Scientific's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Boston Scientific's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Boston Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Boston Scientific's stakeholders.
For many companies, including Boston Scientific, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Boston Scientific Corp, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Boston Scientific's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 4.8348 | Enterprise Value Ebitda 26.7504 | Price Sales 5.6346 | Shares Float 1.5 B | Wall Street Target Price 106.7813 |
Boston Scientific Corp is undervalued with Real Value of 88.37 and Target Price of 106.78. The main objective of Boston Scientific stock analysis is to determine its intrinsic value, which is an estimate of what Boston Scientific Corp is worth, separate from its market price. There are two main types of Boston Scientific's stock analysis: fundamental analysis and technical analysis.
The Boston Scientific stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Boston Scientific is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Boston Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Boston Stock Analysis Notes
About 95.0% of the company shares are held by institutions such as insurance companies. The book value of Boston Scientific was currently reported as 15.78. The company has Price/Earnings To Growth (PEG) ratio of 0.85. Boston Scientific Corp had not issued any dividends in recent years. The entity had 2:1 split on the 6th of November 2003. Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. Boston Scientific operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 41000 people. For more info on Boston Scientific Corp please contact Michael Mahoney at 508 683 4000 or go to https://www.bostonscientific.com.Boston Scientific Quarterly Total Revenue |
|
Boston Scientific Corp Investment Alerts
| Boston Scientific generated a negative expected return over the last 90 days | |
| Boston Scientific has a strong financial position based on the latest SEC filings | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from independent.co.uk: Pfizers experimental weight loss drug shows promise in mid-stage trial |
Boston Largest EPS Surprises
Earnings surprises can significantly impact Boston Scientific's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2013-10-24 | 2013-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2013-04-25 | 2013-03-31 | 0.09 | 0.1 | 0.01 | 11 | ||
2012-07-26 | 2012-06-30 | 0.1 | 0.11 | 0.01 | 10 |
Boston Scientific Environmental, Social, and Governance (ESG) Scores
Boston Scientific's ESG score is a quantitative measure that evaluates Boston Scientific's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Boston Scientific's operations that may have significant financial implications and affect Boston Scientific's stock price as well as guide investors towards more socially responsible investments.
Boston Scientific Thematic Classifications
In addition to having Boston Scientific stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | HealthcareHealthcare institutions that deliver medical services | |
![]() | Obamacare RepealLarge healthcare related equities associated with Obamacare |
Boston Stock Institutional Investors
| Shares | Bollard Group Llc | 2025-06-30 | 20.1 M | Norges Bank | 2025-06-30 | 19.5 M | Amvescap Plc. | 2025-06-30 | 16.9 M | Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main | 2025-06-30 | 16.6 M | Northern Trust Corp | 2025-06-30 | 14.3 M | Goldman Sachs Group Inc | 2025-06-30 | 13.9 M | Massachusetts Financial Services Company | 2025-06-30 | 12.9 M | Ubs Asset Mgmt Americas Inc | 2025-06-30 | 12.8 M | Hhg Plc | 2025-06-30 | 12.2 M | Blackrock Inc | 2025-06-30 | 146.7 M | Vanguard Group Inc | 2025-06-30 | 137.1 M |
Boston Market Capitalization
The company currently falls under 'Mega-Cap' category with a total capitalization of 113.11 B.Boston Profitablity
The company has Net Profit Margin of 0.14 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.21 %, which entails that for every 100 dollars of revenue, it generated $0.21 of operating income.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.12 | 0.14 | |
| Return On Capital Employed | 0.09 | 0.18 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.10 | 0.06 |
Management Efficiency
Boston Scientific Corp has Return on Asset of 0.0576 % which means that on every $100 spent on assets, it made $0.0576 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1268 %, implying that it generated $0.1268 on every 100 dollars invested. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Boston Scientific's Return On Tangible Assets are fairly stable compared to the past year. Return On Capital Employed is likely to rise to 0.18 in 2026, whereas Return On Assets are likely to drop 0.05 in 2026. At this time, Boston Scientific's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 39.2 B in 2026, whereas Other Current Assets are likely to drop slightly above 792.7 M in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 13.46 | 14.13 | |
| Tangible Book Value Per Share | (1.38) | (1.45) | |
| Enterprise Value Over EBITDA | 32.49 | 34.12 | |
| Price Book Value Ratio | 6.94 | 5.90 | |
| Enterprise Value Multiple | 32.49 | 34.12 | |
| Price Fair Value | 6.94 | 5.90 | |
| Enterprise Value | 61.2 B | 64.2 B |
Leadership at Boston Scientific emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Technical Drivers
As of the 8th of February, Boston Scientific shows the Standard Deviation of 2.61, risk adjusted performance of (0.10), and Mean Deviation of 1.37. Boston Scientific Corp technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Boston Scientific Corp Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Boston Scientific price series with the more recent values given greater weights.
Boston Scientific Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Boston Scientific insiders, such as employees or executives, is commonly permitted as long as it does not rely on Boston Scientific's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Boston Scientific insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Boston Scientific Outstanding Bonds
Boston Scientific issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Boston Scientific Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Boston bonds can be classified according to their maturity, which is the date when Boston Scientific Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAY09 | View | |
| BOSTON PPTYS LTD Corp BondUS10112RAX26 | View | |
| BXP 675 01 DEC 27 Corp BondUS10112RBG83 | View | |
| BOSTON SCIENTIFIC P Corp BondUS101137AL15 | View | |
| BXP 245 01 OCT 33 Corp BondUS10112RBF01 | View | |
| BOSTON PROPERTIES LP Corp BondUS10112RBE36 | View | |
| BOSTON PROPERTIES LP Corp BondUS10112RBD52 | View |
Boston Scientific Predictive Daily Indicators
Boston Scientific intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Boston Scientific stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Boston Scientific Corporate Filings
8K | 5th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 4th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 20th of January 2026 Other Reports | ViewVerify | |
8K | 15th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 8th of December 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
F4 | 2nd of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 1st of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Boston Scientific Forecast Models
Boston Scientific's time-series forecasting models are one of many Boston Scientific's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Boston Scientific's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Boston Scientific Bond Ratings
Boston Scientific Corp financial ratings play a critical role in determining how much Boston Scientific have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Boston Scientific's borrowing costs.| Piotroski F Score | 8 | Strong | View |
| Beneish M Score | (2.41) | Unlikely Manipulator | View |
Boston Scientific Corp Debt to Cash Allocation
As Boston Scientific Corp follows its natural business cycle, the capital allocation decisions will not magically go away. Boston Scientific's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Boston Scientific Corp has 11.15 B in debt with debt to equity (D/E) ratio of 0.51, which is OK given its current industry classification. Boston Scientific Corp has a current ratio of 1.42, which is typical for the industry and considered as normal. That said, strategic use of leverage may enable Boston to fund expansion initiatives and generate superior returns. Boston Scientific Total Assets Over Time
Boston Scientific Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Boston Scientific uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Boston Scientific Debt Ratio | 21.0 |
Boston Scientific Corporate Bonds Issued
Boston Short Long Term Debt Total
Short Long Term Debt Total |
|
About Boston Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Boston Scientific prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Boston shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Boston Scientific. By using and applying Boston Stock analysis, traders can create a robust methodology for identifying Boston entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.17 | 0.18 | |
| Operating Profit Margin | 0.20 | 0.20 | |
| Net Profit Margin | 0.14 | 0.15 | |
| Gross Profit Margin | 0.69 | 0.73 |
Current Boston Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Boston analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Boston analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 106.78 | Strong Buy | 34 | Odds |
Most Boston analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Boston stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Boston Scientific Corp, talking to its executives and customers, or listening to Boston conference calls.
Boston Stock Analysis Indicators
Boston Scientific Corp stock analysis indicators help investors evaluate how Boston Scientific stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Boston Scientific shares will generate the highest return on investment. By understating and applying Boston Scientific stock analysis, traders can identify Boston Scientific position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 1.1 B | |
| Common Stock Shares Outstanding | 1.5 B | |
| Total Cashflows From Investing Activities | -5.7 B | |
| Tax Provision | 493 M | |
| Quarterly Earnings Growth Y O Y | 0.185 | |
| 50 Day M A | 93.9016 | |
| Other Operating Expenses | 16.1 B | |
| Forward Price Earnings | 22.0264 | |
| Stock Based Compensation | 266 M |
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.

